PubMed · 1990 · 13 citations · 0 references
MedicineHematologySurgeryHemostasisVascular SurgeryHemolytic DisordersHemorrhage ControlHemorrhagic ShockHemostasis ManagementHemostatic AgentsSplenic PathologyIntravenous Tissue Plasminogen ActivatorPlasminogen ActivatorsSplenic HemorrhageSplenic RuptureSplenic Trauma
Thrombolytic therapy with tissue plasminogen activator (tPA) for acute myocardial infarction may result in major bleeding complications such as gastrointestinal or intracranial bleeding. A case is described of severe splenic hemorrhage and rupture which developed 3 h after completion of tPA infusion for suspected acute myocardial infarction. The patient developed hypovolemic shock with abdominal pain and distension and further evidence of myocardial necrosis. A computed tomography scan of the abdomen was helpful in elucidating the diagnosis, and surgical splenectomy resulted in a good patient outcome, though the period of hypotension had increased the extent of myocardial necrosis.